Chief Executive Carrie Lam Cheng Yuet-ngor said on Tuesday said she would not impose a mainland China-style hard lockdown as ...

Stacker consulted research from Yale Medical School and the World Health Organization to find how SARS-CoV-2 has evolved ...

Paxlovid significantly shortened the time to symptom relief (median, 13 vs 15 days; hazard ratio [HR], 1.27) and resolution ...

The XEC COVID-19 variant is poised to become the dominant variant worldwide. Now is a good time to get an updated COVID ...

Northeastern University professors of pharmacy say the updated COVID-19 vaccines available for fall and winter of 2024 are a ...

Since 2020, COVID-19 has surged across the nation and the world. With variants like Omicron, Delta, Alpha and more, this ...

An abundance of evidence indicates the mRNA COVID-19 vaccines are remarkably safe and work well to protect against severe ...

A new retrospective cohort study conducted in Dubai shows that the antiviral nirmatrelvir plus ritonavir, sold as Paxlovid, ...

KP.3.1.1 is still the dominant COVID-19 variant in the United States ... of the closely related Omicron lineages KS.1.1 and KP.3.3." The variant, which first appeared in Berlin in late June ...

Updated COVID-19 vaccines targeting JN.1-lineage omicron variants of the coronavirus are now available in the U.S. for the fall and winter seasons. Here we answer common questions about the latest ...

The report, riddled with lies and misinformation, is a crude justification for the subordination of public health and lives ...

1, Delta, B.1.617.2, BA.5. Omicron BF.7 strain is driving the current wave of Covid infections in China. As of now, India reported four cases of the Omicron sub-variant BF.7 which is a sub-lineage ...